Company Profiles

driven by the PitchBook Platform

Polyphor

Polyphor
1996 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
13 INVESTORS
Description

Developer of macrocycle drugs intended to bring novel antibiotics and medicines for high medical needs to patients. The company's macrocycle drugs address infections caused by resistant Gram-negative pathogens, enabling pharma companies to get assisted in research programs addressing difficult targets through its proprietary macrocycle technology platform.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
Hegenheimermattweg 125
4123 Allschwil
Switzerland

+41 061 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Polyphor’s full profile, request a free trial.

Polyphor Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 12-Apr-2017 $10M 0000 Completed Clinical Trials - Phase 2
5. Grant 09-Feb-2017 00.00 Completed Clinical Trials - Phase 2
4. Grant 23-Mar-2016 000 Completed Clinical Trials - Phase 2
3. Secondary Transaction - Private 17-Jun-2010 Completed Clinical Trials - Phase 2
2. Later Stage VC Completed Product Development
1. Early Stage VC 18-Aug-1999 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Polyphor Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Varuma Venture Capital Minority 000 0000 000000 0
Wellcome Trust Limited Partner 000 0000 000000 0
Cystic Fibrosis Foundation Corporation 000 0000 000000 0
Ingro Finanz Other Minority 000 0000 000000 0
Bachem Corporation Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Polyphor Executive Team (10)

Name Title Board
Seat
Contact
Info
Giacomo Di Nepi Chief Executive Officer
Kalina Scott Chief Financial Officer
Debra Barker MD Chief Medical & Development Officer
Daniel Obrecht Ph.D Chief Scientific Officer & Co-Founder
Helmut Kessmann Ph.D Head, Business Development Pharma

4 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Polyphor Board Members (13)

Name Representing Role Since Contact
Info
Andreas Wallnöfer Ph.D BioMedPartners Board Member 000 0000
Anja König Ph.D Novartis Venture Fund Board Member 000 0000
Argeris Karabelas Polyphor Chairman 000 0000
Bernard Bollag Self Board Member 000 0000
Jean-Jacques Garaud MD Self Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com